Author: Healio ophthalmology

30th Asia-Pacific Academy of Ophthalmology Congress

With the concerted efforts of world-leading experts in ophthalmology and visual sciences, the 30th APAO Congress will showcase the best of ophthalmology and visual sciences. There will be four subspecialty day programs focusing on cataract, glaucoma, refractive surgery and retina. As usual, the 30th APAO Congress will provide ample opportunities for delegates to make friends and renew friendships. Registration is now open, and abstract submissions open on June 1. Please visit 2015.apaophth.org for more information. You can also visit the Academy’s Facebook page at www.facebook.com/pages/Asia-Pacific-Academy-of-Ophthalmology/1428503844066257 to stay tuned with the (Read more...)

VIDEO: Humanitarian award winner encourages efforts to eradicate curable blindness

WAIKOLOA, Hawaii — At Hawaiian Eye, Biosyntrx Thornton Humanitarian Award winner, Geoffrey C. Tabin, MD, discusses the efforts by Biosyntrx and the Hawaiian Eye Foundation to bring American doctors to underdeveloped nations to perform surgeries, as well as to teach and develop new ophthalmologists in regions of the world where they are desperately needed.

VIDEO: Vancomycin ‘rarely’ associated with HORV

WAIKOLOA, Hawaii — At Hawaiian Eye, David F. Chang, MD, discussed the association found between vancomycin and HORV reported in 12 cataract surgery cases, and the steps anterior segment surgeons and retinal specialists are taking together to investigate the causes.Retinal specialists have collected a dozen cases of hemorrhagic occlusive retinal vasculitis (HORV), according to Chang.

Speaker: Intracameral injections effective in antibiotic prophylaxis of endophthalmitis

WAIKOLOA, Hawaii —Intracameral injections have shown to be an effective method in the antibiotic prophylaxis of endophthalmitis following cataract surgery, according to a speaker here. “Endophthalmitis is obviously is a topic that we are all concerned about, and we are all adept at many of the risk factors,” Francis S. Mah, MD, said in a presentation at Hawaiian Eye reviewing the most recent literature regarding endophthalmitis. “Some of these papers were more recent and help us to fill out what potentially might have changed or might be current as far (Read more...)

Progress slow but steady for cell, gene therapies for AMD

WAIKOLOA, Hawaii — Progress in cell and gene therapies for the treatment of wet and dry age-related macular degeneration is evidenced by advancement, albeit slow, of clinical trials, according to a speaker here.Janssen and Ocata are both initiating phase 2 trials of cell therapy for atrophic AMD, and a phase 2 study of NeuroTech’s implant platform that combines cell and gene therapy for treatment of wet AMD is ongoing, Allen C. Ho, MD, told colleagues at Retina 2016.

Ultra-widefield imaging visualizes DR outside ETDRS standard fields

WAIKOLOA, Hawaii — Developments in widefield imaging continue to progress at a rapid pace and the technology may have a place in detecting and staging diabetic retinopathy, according to a speaker here.Historically, diabetic retinopathy severity has been staged based on ETDRS seven standard fields; however, recent pilot studies that looked beyond those fields using ultra-widefield imaging found patients with peripheral lesions were at increased risk for progression to proliferative diabetic retinopathy, SriniVas R. Sadda, MD, told colleagues at Retina 2016.

Speaker of the Day awardees named for Tuesday’s Hawaiian Eye/Retina 2016 program

WAIKOLOA, Hawaii — David F. Chang, MD, who moderated Tuesday’s interactive Cataract Surgery Complications: You Make the Call program, was named Speaker of the Day for the Comprehensive Ophthalmology Program. Roger F. Steinert, MD, who co-moderated with Chang another section on Tuesday, Current Controversies: Endophthalmitis Prophylaxis, shared with the audience Chang’s year-long commitment to putting together much of Monday’s and Tuesday’s programming. Chang is clinical professor, University of California, San Francisco.

Patients treated with ranibizumab for wet AMD may be at risk of developing macular atrophy

WAIKOLOA, Hawaii — Patients who are treated with ranibizumab for neovascular AMD may be at risk for developing macular atrophy, according to a speaker here.“Is [macular atrophy] truly associated with VEGF inhibition or is this the natural disease progression? Other conditions in which we treat VEGF inhibition aggressively such as diabetic macular edema or retinal vein occlusion do not develop the macular atrophy we see in neovascular AMD,” Diana V. Do, MD, said here at Retina 2016.

New advances in IOL technology increase patient satisfaction

WAIKOLOA, Hawaii — The advancement in IOL technology has increased patient satisfaction, according to a speaker here. “The new IOLs we have today are dramatically improved and have really improved patient satisfaction,” Eric D. Donnenfeld, MD, said at Hawaiian Eye. “And we have a lot of new technology on the horizon as well. It is a very exciting time to be involved in presbyopia correction.”

DMEK in an aphakic, post-vitrectomy eye

This video shows a case in our series of Descemet’s membrane endothelial keratoplasty in challenging cases, soon due for publication. The patient was referred to our clinic because of extensive corneal edema, due to multiple surgeries, following complicated cataract surgery. In addition to large peripheral anterior synechia (PAS) and aphakia, multiple vitrectomies were performed due to retinal detachments.